| Hydroxychloroquine studied in …STUDIED_INderived85 of 85show fewer |
|---|
| → studied in | NCT04464759Phase 1/Phase 2 · active not recruiting A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825454Phase 2 · not yet recruiting Pilot Study of Hydroxychloroquine for the Treatment of AIMSS · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201457Phase 1/Phase 2 · active not recruiting A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814339Phase 1 · not yet recruiting Hydrochloroquinine & Decitabine With Venetoclax in AML · 85 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01480154Phase 1 · active not recruiting Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer · 85 trials list this drug (15 active) | — | — | Malignant Solid Neoplasm,Cutaneous Melanoma,Malignant Prostate Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750067Phase 2 · recruiting Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04527549Phase 2 · terminated Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01494155Phase 2 · completed Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669197Phase 2 · completed Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer · 85 trials list this drug (15 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032406Phase 2 · active not recruiting CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843188Phase 2 · active not recruiting Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer · 85 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523857Phase 2 · recruiting ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598595Phase 1/Phase 2 · active not recruiting Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma · 85 trials list this drug (15 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03825289Phase 1 · terminated Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05842174Phase 1/Phase 2 · recruiting Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma · 85 trials list this drug (15 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518110Phase 2 · terminated PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04132505Phase 1 · completed Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524702Phase 2 · completed Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971744Phase 2 · recruiting Autophagy Maintenance (AUTOMAIN) · 85 trials list this drug (15 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977470Phase 2 · active not recruiting Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations · 85 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05221320Phase 2 · terminated Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies · 85 trials list this drug (15 active) | — | — | Solid Neoplasm,Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037437Phase 2 · completed Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer · 85 trials list this drug (15 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506973Phase 1/Phase 2 · completed A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377179Phase 2 · completed A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma · 85 trials list this drug (15 active) | — | — | Intrahepatic Cholangiocarcinoma,Cholangiocarcinoma,Extrahepatic Cholangiocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04379492Phase 2 · withdrawn A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06939582Phase 1/Phase 2 · recruiting Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774472Phase 1/Phase 2 · completed Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04386057Phase 2 · completed LY3214996 +/- HCQ in Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214418Phase 1/Phase 2 · terminated Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced Malignancies · 85 trials list this drug (15 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145297Phase 1 · completed Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas · 85 trials list this drug (15 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06328387Phase 1/Phase 2 · unknown HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05689359Phase 2 · withdrawn Evaluation of Hydroxychloroquine to Prevent CIPN · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm,Early Stage Breast Carcinoma,Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316340Phase 2 · completed Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer · 85 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513211Phase 1/Phase 2 · completed Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer · 85 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03215264Phase 1 · completed To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer · 85 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566133Phase 2 · terminated Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). · 85 trials list this drug (15 active) | — | — | Malignant Bile Duct Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00786682Phase 2 · terminated Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer · 85 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00765765Phase 1/Phase 2 · terminated Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00813423Phase 1 · completed Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy · 85 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733000Phase 2 · recruiting CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors · 85 trials list this drug (15 active) | — | — | Malignant Solid Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01023737Phase 1 · completed Hydroxychloroquine + Vorinostat in Advanced Solid Tumors · 85 trials list this drug (15 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04316169Phase 1 · withdrawn Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer · 85 trials list this drug (15 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649947Phase 2 · completed Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II · 85 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00962845early Phase 1 · completed Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726596Phase 2 · completed Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer · 85 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449758Phase 4 · completed Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394182NA · suspended Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04163107Phase 1 · completed Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma · 85 trials list this drug (15 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015324Phase 1 · completed Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors · 85 trials list this drug (15 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257424Phase 1/Phase 2 · completed Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04381988Phase 2 · terminated A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy · 85 trials list this drug (15 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084872Phase 2/Phase 3 · unknown Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients · 85 trials list this drug (15 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01006369Phase 2 · completed Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer · 85 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03754179Phase 1/Phase 2 · unknown Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03081702Phase 1/Phase 2 · completed A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722369Phase 2 · terminated STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) · 85 trials list this drug (15 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266057Phase 1 · completed Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer · 85 trials list this drug (15 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04392128Phase 2 · withdrawn Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) · 85 trials list this drug (15 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01897116Phase 1 · completed A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma · 85 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03400254Phase 1/Phase 2 · withdrawn Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") · 85 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01510119Phase 1/Phase 2 · completed Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma · 85 trials list this drug (15 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04341207Phase 2 · unknown Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568880Phase 1 · completed Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550367Phase 1/Phase 2 · completed Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC) · 85 trials list this drug (15 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486603Phase 1/Phase 2 · completed Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01128296Phase 1/Phase 2 · completed Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01206530Phase 1/Phase 2 · completed FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer · 85 trials list this drug (15 active) | — | — | Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00909831Phase 1 · completed Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment · 85 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01978184Phase 2 · completed Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01602588Phase 2 · completed A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) · 85 trials list this drug (15 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631252Phase 1 · terminated Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia · 85 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414776Phase 1 · terminated Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02765594Phase 4 · unknown Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy · 85 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01689987Phase 1 · completed Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma · 85 trials list this drug (15 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273805Phase 2 · completed Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer · 85 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00728845Phase 1/Phase 2 · terminated Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer · 85 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01828476Phase 2 · terminated Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer · 85 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02421575early Phase 1 · terminated Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance · 85 trials list this drug (15 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026844Phase 1 · terminated Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) · 85 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01144169Phase 1 · terminated Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma · 85 trials list this drug (15 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771056Phase 2 · terminated Hydroxychloroquine in Untreated B-CLL Patients · 85 trials list this drug (15 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00714181Phase 1 · completed Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors · 85 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417403Phase 1 · terminated Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases · 85 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396200early Phase 1 · completed Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine · 85 trials list this drug (15 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227135Phase 2 · unknown Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia · 85 trials list this drug (15 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |